Welcome to our dedicated page for Owlet SEC filings (Ticker: OWLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to pinpoint how Owlet’s Smart Sock sales or FDA milestones affect revenue, but buried in dense disclosures? You’re in the right place. Our Owlet SEC filings hub surfaces exactly where those answers live—without making you wade through every footnote.
Start with the Owlet quarterly earnings report 10-Q filing to track connected-nursery subscribers, margin trends and inventory write-downs. Need the bigger picture? The Owlet annual report 10-K simplified by Stock Titan’s AI highlights regulatory pathways, data-privacy risks and long-term hardware roadmaps. For sudden product updates, our engine flags each Owlet 8-K material events explained entry within minutes of hitting EDGAR.
Many users ask, “How do I see Owlet insider trading Form 4 transactions in real time?” One click shows every Owlet Form 4 insider transactions real-time alert, letting you monitor founder and pediatric-advisor stock moves. Curious about pay packages? The Owlet proxy statement executive compensation tab breaks down leadership incentives next to subscriber-growth targets.
- AI-powered summaries translate accounting language into plain English—understanding Owlet SEC documents with AI really is that simple.
- Real-time alerts ensure you never miss a filing, from routine certifications to critical amendments.
- Side-by-side charts offer quick Owlet earnings report filing analysis across quarters.
Whether you’re scanning Owlet executive stock transactions Form 4 for sentiment signals or checking warranty-return rates in footnote 15, Stock Titan delivers the context investors need—fast, factual and always up to date.
Owlet, Inc. (OWLT) reported an insider ownership change. On 10/10/2025, a director exchanged 131,195 warrants for 80,235 shares of Class A common stock at a ratio of approximately 0.61 shares per warrant (Transaction Codes: A for shares acquired, D for warrants disposed).
The warrants were initially issued in February 2023 in connection with the Company’s Series A Convertible Preferred Stock. Following the transaction, the director beneficially owns 419,004 shares directly and holds 0 warrants. The warrants carried a $4.44 exercise price; the filing lists a $0 price for the derivative security exchange.
Owlet, Inc. (OWLT): Director Form 4 filing — On 10/10/2025, a director acquired 107,626 shares of Class A common stock. Following the transaction, the director beneficially owns 233,030 shares, held directly.
The shares were issued in exchange for previously held warrants tied to the company’s Series A (February 2023) and Series B (February 2024) preferred financings, at approximate exchange ratios of 0.61 and 0.56 shares per warrant. Two warrant positions for 131,195 and 48,621 underlying shares were disposed, leaving zero derivative securities.
Owlet, Inc. (OWLT): A reporting person acquired 686,469 shares of common stock on October 10, 2025 via an exchange of previously issued warrants and now directly owns 1,567,468 shares.
The transaction exchanged warrants issued in connection with the company’s Series A and Series B financings for common shares at approximate ratios of 0.61 and 0.56 shares per warrant, respectively. Specifically, 712,915 warrants initially issued on 02/17/2023 (expiring 02/17/2028) and 444,601 warrants initially issued on 02/29/2024 (expiring 03/01/2029) were converted (Transaction Code C). Following the exchange, the reported balance of these derivative securities is 0.
Trilogy Equity Partners filed Amendment No. 4 to its Schedule 13D on Owlet, Inc. (Class A Common Stock), reporting beneficial ownership of 2,022,178 shares, or approximately 8.7% of the class.
The reported stake consists of 1,567,468 common shares, plus 158,309 shares issuable upon conversion of Series A Convertible Preferred and 296,401 shares issuable upon conversion of Series B Convertible Preferred, as disclosed. Owlet had 22,788,420 shares outstanding as of October 10, 2025.
Trilogy has sole voting and dispositive power over the reported shares. On October 10, 2025, Trilogy exchanged 712,915 Series A-related warrants and 444,601 Series B-related warrants for common shares at exchange ratios of 0.61 and 0.56 shares per warrant, respectively.
Owlet, Inc. (OWLT) received an amended Schedule 13D (Amendment No. 5) from Eclipse-affiliated funds and Lior Susan, updating beneficial ownership and disclosing a completed warrant-for-share exchange. On
Reported beneficial holdings include: Eclipse Continuity Fund I at 1,066,472 shares (4.7%), Eclipse Ventures Fund I at 968,694 shares (4.3%), and Eclipse Early Growth Fund I at 7,621,469 shares (30.8%), which includes 1,955,800 shares issuable upon preferred stock conversion. Lior Susan is reported at 9,656,635 shares (40.5%). Percentages reference 22,788,420 Class A shares outstanding as of
Owlet, Inc. (OWLT): Eclipse-affiliated holders reported an exchange of previously issued warrants for common stock on October 10, 2025. Eclipse Early Growth Fund I, L.P. acquired 3,898,906 shares of common stock in the exchange, and the related Series A and Series B warrants were disposed.
Following the transactions, 5,665,669 shares were beneficially owned indirectly (per footnote (2)). Other Eclipse-managed funds reported indirect holdings of 968,694 shares (per footnote (3)) and 1,066,472 shares (per footnote (4)). The filing identifies the reporting persons as Director, 10% Owner, and “Director by Deputization.”
The exchange covered warrants originally issued in February 2023 (Series A) and February 2024 (Series B) at approximate exchange ratios of 0.61 and 0.56 shares per warrant, respectively, and is noted as exempt under Rule 16b-3.
Owlet (OWLT): Director and 10% owner reports warrant-for-share exchange. On 10/10/2025, Eclipse Early Growth Fund I, L.P. exchanged previously issued Series A and Series B warrants for 3,898,906 shares of Common Stock, at approximate ratios of 0.61 and 0.56 shares per warrant, respectively. The transaction was reported as exempt under Rule 16b-3.
Following the exchange, indirect beneficial ownership reported includes 5,665,669 shares via Eclipse EGF I, 968,694 shares via Eclipse Ventures Fund I, and 1,066,472 shares via Eclipse Continuity Fund I. The Series A (5,300,291 underlying shares) and Series B (1,166,935 underlying shares) warrant positions were reduced to 0.
Owlet (NYSE: OWLT) reported results of its 2025 annual meeting and completed a warrant exchange. Stockholders approved an amendment to the 2021 Incentive Award Plan to increase shares available for issuance by 375,000 shares, subject to the plan’s existing annual increase mechanics. Stockholders also approved a Charter amendment adding officer exculpation to the extent permitted by Delaware law; the Certificate of Amendment became effective on October 10, 2025.
Stockholders ratified PricewaterhouseCoopers LLP for the fiscal year ending December 31, 2025 and elected three Class I directors. They also approved the issuance of shares related to warrant exchanges. Pursuant to the approved exchanges, holders swapped Series A and Series B warrants relating to an aggregate of 9,014,758 warrant shares (7,215,737 + 1,799,021) for 5,426,429 newly issued shares of common stock. The company consummated the exchanges on October 10, 2025. After giving effect, common shares outstanding were 22,788,420.
FAQ
What is the current stock price of Owlet (OWLT)?
What is the market cap of Owlet (OWLT)?
